Monday, February 8, 2016

DIABETIC MEDICATION UPDATES/INJECTABLE MEDICATIONS



DIABETIC MEDICATION UPDATES/INJECTABLE MEDICATIONS

Introduction
  • Diabetes is disease resulting from an inability to use and/or produce insulin, a hormone made by the pancreas
  • If the body cannot produce insulin (type 1 diabetes) or cannot use it properly (type 2 diabetes), blood glucose levels build up in the blood. Diabetes is diagnosed based on elevated blood glucose levels.
           What is diabetes?
}  Diabetes mellitus (DM) is a group of diseases characterized by high levels of blood glucose resulting from defects in insulin production, insulin action, or both.
}  The term diabetes mellitus describes a metabolic disorder of multiple aetiology characterized by chronic hyperglycaemia with disturbances of carbohydrate, fat and protein metabolism resulting from defects in insulin secretion, insulin action, or both.
}  The effects of diabetes mellitus include long–term damage, dysfunction and failure of various organs.
    Types Of Diabetes
}  Type 1 Diabetes Mellitus
}  Type 2 Diabetes Mellitus
}  Gestational Diabetes
}  Other types:
}  LADA (Latent Autoimmune Diabetes Of Adult)
}  MODY (maturity-onset diabetes of youth)
}  Secondary Diabetes Mellitus
      The goal of diabetes management:
  • To keep levels of blood glucose, blood pressure, and cholesterol as close to the normal range as possible.
  •  A major study, the Diabetes Control and Complications Trial (DCCT), sponsored by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), showed that keeping blood glucose levels close to normal reduces the risk of developing major complications of type 1 diabetes.
     Management of diabetus mellitus:
  • The major components of the treatment of diabetes are:
  • Diet and Exercise
  • Oral hypoglycaemic therapy
  • Insulin Therapy
  • Non insulin injectable medication 
Non-insulin injectable
  • Pramlintide (Symlin)
  • Liraglutide (Victoza)
  • Exenatide (Byetta)
  • Exenatide ER (Bydureon)
  • Dulaglutide (Trulicity)


1. Pramlintide (Symlin)
  • What it is: It's a man-made version of a hormone called amylin, which your pancreas makes along with insulin when your blood sugar levels rise.
  • Who can take it: It's approved for people with type 1 diabetes who are taking insulin. It's also OK'd for people with type 2 diabetes who are taking insulin, a sulfonylurea drug, or metformin. If you think you could get pregnant, tell your doctor, since researchers haven't studied this drug in pregnant women.
  • What it does: You take pramlintide with insulin after a meal. The two drugs work together to lower your blood sugar. Pramlintide also helps you digest food more slowly. This puts less sugar into your bloodstream. In addition to controlling your A1C levels, pramlintide helps lessen your appetite, so you eat less.
  • Side effects: Nausea is the most common side effect. Starting this drug at a low dose and increasing it slowly can help fight this side effect. Others include less appetite, vomiting, stomach pain, tiredness, dizziness, or indigestion.The drug can also cause low blood sugar if you don't adjust the amount of insulin you're taking.
2. Liraglutide (Victoza)/ Albiglutide (Tanzeum)
  • What it is: This is another GLP-1 drug. You inject it once a day. It helps your body release more insulin. This helps move glucose from your bloodstream into your cells.
  • Who can take it: Adults who have type 2 diabetes but haven’t had results with other treatment. You take it in combination with metformin or a sulfonylurea drug. If you're planning to get pregnant, talk with your doctor. Liraglutide hasn’t been studied in pregnant women.
  • What it does: Like the other GLP-1 drugs, liraglutide cues your pancreas to release insulin. This moves glucose out of your bloodstream and into your cells. It also limits how much of the hormone glucagon your body makes. This substance prompts your liver to release stored sugar. The drug also slows digestion.
  • Side effects: The most common side effects include nausea, diarrhea, and headache. Inflammation of the pancreas (pancreatitis), which may be severe, is another side effect.
  • All GLP-1 drugs, including liraglutide, have a boxed warning noting that in animal studies, this type of drug has been linked to thyroid cancer in some rats and mice. Experts don't know whether it has the same effect in people.
  • It's possible to have an allergic reaction to liraglutide, or to get low blood sugar while you're taking it. If you get dehydrated from nausea, vomiting, or diarrhea, that could lead to kidney failure.
3. Exenatide (Byetta):
  • What it is:Exenatide was the first GLP-1 drug approved by the FDA.Byetta came first. You take it as a shot twice daily. Bydureon is the newer, extended-release version, which you inject once a week. You can't take both drugs.
  • Who can take it: Adults with type 2 diabetes for whom other treatment hasn't worked. If you think you might get pregnant, talk to your doctor. Researchers haven't studied this drug in pregnant women.
  • What it does: Like other GLP-1 drugs, exenatide tells your pancreas to release insulin, which moves glucose out of your bloodstream and into your cells. It also limits how much glucagon your body makes. This hormone prompts your liver to release stored sugar. The drug slows digestion, too.
  • Side effects: The most common ones include nausea, vomiting, diarrhea, feeling jittery, dizziness, headache, acid stomach, constipation, and weakness. These usually go away after the first month of treatment. Inflammation of the pancreas (pancreatitis), which may be severe, is another side effect.
§  The FDA has also received reports of kidney failure in people taking this drug. All GLP-1 drugs, including both types of exenatide, have a boxed warning noting that in animal studies, this type of drug has been linked to thyroid cancer in some rats and mice. Experts don't know whether it has the same effect in people. It's possible you could get low blood sugar or have an allergic reaction to the drug.
4. Exenatide Extended Release:
  • Exenatide extended release (brand name Bydureon) is taken as single weekly dose along with diet and exercise to control blood glucose in type 2 diabetes.  It helps the pancreas to make insulin while decreasing glucose release from the liver when blood glucose are high. It also slows digestion and keeps individuals feeling full longer and decreases appetite. As with standard exenatide, there is an increased risk of hypoglycemia when used in combination with Sulfonylureas. This medication is not a substitute for insulin, should not be used in patients withtype 1 diabetes or diabetic ketoacidosis, and is not recommended to be used with insulin.
5. Dulaglutide (Trulicity):
  • What it is: This is another GLP-1 drug. Unlike the others, you inject it only once a week. It helps your body release more insulin and move glucose from your bloodstream into your cells.
  • Who can take it: Adults with type 2 diabetes who have not had success with other diabetes treatment. You can take it alone, or in combination with metformin, pioglitazone, or a sulfonylurea drug. If you're planning to get pregnant, tell your doctor, since researchers haven't studied this drug in pregnant women.
  • What it does: Like other GLP-1 drugs, dulaglutide prompts your pancreas to release insulin, which moves glucose out of your bloodstream and into your cells. It also limits how much of the hormone glucagon your body makes, since glucagon normally spurs your liver to release stored sugar. The drug slows digestion, too.
  • Side effects: The most common side effects include nausea, vomiting, diarrhea, belly pain, and less appetite. All GLP-1 drugs, including dulaglutide, have a boxed warning noting that in animal studies, this type of drug has been linked to thyroid cancer in some rats and mice. Experts don't know whether it has the same effect in people.
Insulin Therapy:
Short-term use:
§  Acute illness, surgery, stress and emergencies
§  Pregnancy
§  Breast-feeding
§  Insulin may be used as initial therapy in type 2 diabetes
§  in marked hyperglycaemia
§  Severe metabolic decompensation (diabetic ketoacidosis, hyperosmolar nonketotic coma, lactic acidosis, severe hypertriglyceridaemia)
Long-term use:
§  If targets have not been reached after optimal dose of combination therapy or BIDS, consider change to multi-dose insulin therapy. When initiating this,insulin secretagogues should be stopped and insulin sensitisers e.g. Metformin or TZDs, can be continued.
INSULIN REGIMENS
§  The majority of patients will require more than one daily injection if good glycaemic control is to be achieved. However, a once-daily injection of an intermediate acting preparation may be effectively used in some patients.
§  Twice-daily mixtures of short- and intermediate-acting insulin is a commonly used regimen.
§  In some cases, a mixture of short- and intermediate-acting insulin may be given in the morning. Further doses of short-acting insulin are given before lunch and the evening meal and an evening dose of intermediate-acting insulin is given at bedtime.
§  Other regimens based on the same principles may be used
§  A regimen of multiple injections of short-acting insulin before the main meals, with an appropriate dose of an intermediate-acting insulin given at bedtime, may be used, particularly when strict glycaemic control is mandatory.
Overview of Insulin and Action:
SOME EXAMPLES OF ORAL MEDICATIONS USED FOR DIABETES?
1. Sulfonylureas
Stimulates the pancreas to release more insulin, both right after a meal and then over several hours
  • Chlorpropamide (Diabinese)
  • Glyburide (Micronase, Diabeta,Glynase PresTab)
  • Glipizide (Glucotrol, Glucotrol XL)
  • Glimepiride (Amaryl)
  • Tolbutamide
  • Acetohexamide
  • Tolazamide (Tolinase)
2. Meglitinides and D-Phenylalanine Derivatives
This type of pill helps your body make more insulin for a short period of time right after meals. The insulin helps keep your blood glucose from going too high after you eat, a common problem in people with diabetes.
  • Nateglinide (Starlix)
  • Repaglinide (Prandin)
3. Biguanides
This type of medicine, which comes in pill or liquid form, lowers the amount of glucose made by your liver. Then your blood glucose levels don’t go too high. This type of medicine also helps treat insulin resistance. With insulin resistance, your body doesn’t use insulin the way it should. When your insulin works properly, your blood glucose levels stay on target and your cells get the energy they need. This type of medicine improves your cholesterol levels. It also may help you lose weight.  Cheap, well tested and often the first drug for doctors try.
  • Metformin (Glucophage, Glucophage XR, Riomet, Fortamet, Glumetza)
  • Alpha-Glucosidase Inhibitors
  • Acarbose (Precose)
  • Meglitol (Glyset)
4. DPP-4 Inhibitor
Improves insulin level after a meal and lowers the amount of glucose made by your body.
  • Sitagliptin (Januvia)
  • Sitagliptin (Januvia)
5.Thiazolidinediones  (TZDs)
  • This type of pill helps treat insulin resistance. With insulin resistance, your body doesn’t use insulin the way it should. Thiazolidinediones help your insulin work properly.
  • Rosiglitazone (Avandia)
  • Pioglitazone*  (Actos)
6. Alpha-glucosidase Inhibitors
  • Slows down the digestion of foods high in carbohydrate, such as rice, potatoes, bread, milk, and fruit.
  • Acarbose (Precose)
  • Miglitol (Glyset)
7. Bile Acid Sequestrants
A cholesterol medication which can also help to lower blood glucose.
·         Colesevelam (Welchol)
8. Combination Pills
  • Oral diabetes medications may also come in combination tablets such as
  • Pioglitazone & metformin) (Actoplus Met)
  • Glyburide & metformin (Glucovance)
  • Glipizide & metformin (Metaglip)
  • Sitagliptin & metformin (Janumet)
  • Saxagliptin & metformin (kombiglyze )
  • Repaglinide & metformin (Prandimet)
  • Pioglitazone & glimepiride (Duetact)
  • Rosiglitazone/ glimepiride (Avandaryl)
DIABETIC DIET
Diet is a basic part of management in every case. Treatment cannot be effective unless adequate attention is given to ensuring appropriate nutrition.
Dietary treatment should aim at:
§  ensuring weight control
§  providing nutritional requirements
§  allowing good glycaemic control with blood glucose levels as close to normal as possible
§  correcting any associated blood lipid abnormalities
The following principles are recommended as dietary guidelines for people with diabetes:
§  Dietary fat should provide 25-35% of total intake of calories but saturated fat intake should not exceed 10% of total energy. Cholesterol consumption should be restricted and limited to 300 mg or less daily.
§  Protein intake can range between 10-15% total energy (0.8-1 g/kg of desirable body weight). Requirements increase for children and during pregnancy. Protein should be derived from both animal and vegetable sources.
§  Carbohydrates provide 50-60% of total caloric content of the diet. Carbohydrates should be complex and high in fibre.
§  Excessive salt intake is to be avoided. It should be particularly restricted in people with hypertension and those with nephropathy.
EXERCISE
}  Physical activity promotes weight reduction and improves insulin sensitivity, thus lowering blood glucose levels.
}  Together with dietary treatment, a programme of regular physical activity and exercise should be considered for each person. Such a programme must be tailored to the individual’s health status and fitness.
}  People should, however, be educated about the potential risk of hypoglycaemia and how to avoid it.



Tuesday, March 24, 2015

Pressure Ulcers



Pressure Ulcers
The Skin;
  • Human body’s largest organ
  • Body’s first line of defense
Functions of the Skin:
  • Protection
  • Regulation
  • Sensation
  • Metabolism
  • Communication
Where do they form?
pressure points of the body
STATISTICS
  1. 70% occur in people over 65 yrs
  2. 2-6 times greater risk of mortality
  3. 95%  it occur lower body,   in sacrum(65%) and heal (30%)
  4. Shoulder, heel, and ear were the favorite sites of newly developed Pressure ulcer
 How it look clinically?
  1. Rounded, crater like shapes with regular edges
  2. Over bony prominences, but can take on the shape of the bone
  3. Usually dark regular base that do not bleed easily
  4. Foul odor from ulcer
  5. Warm/swollen skin
  6. 6. Fever, weakness, and confusion if infection spread to blood or other areas of body
                Bed Sores
ARE ALL ULCERS PRESSURE ULCERS?
  • NO!
  • Trauma, skin tears, moisture, arterial, venous, diabetic ulcer. 
  • These are often confused with Pressure ulcers.
  • Pressure Ulcers are over bony prominences as a result of pressure.
  • Do not stage any other ulcer besides pressure ulcers
Factors causing pressure ulcer?
Intrinsic factors:
  • Malnutrition and dehydration
  • Critical illness
  • Bedridden/wheel chair.
  • Incontinence
  • Age/Fragile skin
  • Chronic diseases
  • Infection, 0besity
  • Smoking
Extrinsic factors:
  • Friction
  • Shear
  • Dryness
  • Moisture
  • Pressure
Risk Factors
  • When you see even one or two of these risk factors, be on the lookout. This resident is at greater risk of developing a pressure ulcer.
What does it mean to “stage” a pressure ulcer?
Pressure ulcers are graded or “staged” to indicate the amount of tissue damage
  • Stage-1 Reddened area of skin
  • Stage-2 Blister/Open Sore
  • Stage-3 Crater (bowl shaped depression on surface)
  • Stage-4 Damage to muscle or bone
http://www.mountainside-medical.com/product_images/uploaded_images/stages-of-pressure-sores.jpg  stages

MANAGEMENT PROCESS OF PRESSURE ULCER
1. Risk assessment (RA)
Braden scale
Criteria
Score
1
2
3
4
1. sensory perception
unresponsive
responsive to pain stimuli
response to verbal  commends
No impairment
2. Moisture
Constantly moist
Often moist but not always
Occasionally moist
Rarely moist
3. Activity
Bed fast
 chair fast
Walk  occasionally
Walks frequently
4. Mobility
5. Nutrition
Completely immobile
Very poor
Very limited
Probably adequate
Slightly limited
Adequate
No limitations
Excellent
6. friction and shear
Problem
Potential problem
No apparent problem
§       




















Interpretation of Braden scale
S.NO
CRITERIA
SCORE
1
VERY HIGH RISK
9 or less
2
HIGH RISK
10-12
3
MODERATE RISK
13-14
4
MILD RISK
15-18
5
NO RISK
19-23






Norton scale
Criteria
                                       Score
4
3
2
1
Physical condition
Good
Fair
Poor
Very bad
Mental condition
Alert
Apathy
Confused
Stupors
Activity
Ambulant
Walks  with help
Chair bound
Bed fast
Mobility
Full
Slightly impaired
Very limited
Immobilized
Incontinence
None
Occasionally
Usually urinary
Urinary and fecal

>18
LOW RISK
14-18
MEDIUM RISK
10-14
HIGH RISK
<10
VERY HIGH RISK

2. Systematic skin assessment (SSA)
  • Every time you change, help to the toilet, dress, bathe, transfer, and/or turn a resident... you have a chance to check and care for a resident’s skin.
What to look for
on the skin
  • An area of skin that is noticeably different than the surrounding area
  • It may look red, and the redness does not “fade” when the skin is touched, and released (blanched).
lower_back_buttocks_CU
Residents with darker skin
For residents with darker skin, the skin may look darker or lighter than the surrounding skin.
Skin may look a little: red, blue, or purple in color.
AA_ECUskn
Another thing to try...
Gently feel for a change in skin temperature: it may feel warmer or cooler than the surrounding area.
A “suspicious area” may feel "spongy“ or "raised".
Tip: Good Lighting
When you check a resident’s skin, be sure to have good lighting.
3. Reduction of risk factors  
Reduction of risk factor
TREATMENT TEAM

Treatment:
Pressure management
1.      Patients who are capable of shifting their weight every 10 minutes should be encouraged to do so.
2.       Reposition every 2 hours in case of bed ridden. After repositioning use a pillow to support the new position in the bed or chair
3.      Patients who are bedbound should be positioned at a 30° angle
4.      Heels elevated off mattress supported by pillows under the legs
5.      Use a pillow to keep the knees and heels from rubbing together
6.      Use draw sheet and trapeze if possible to decrease friction
7.      Do not position, if possible, over area of break  down
8.      NEVER massage reddened areas (this is friction and will increase break down)
9.      Keep in mind heel pads and elbow pads prevent FRICTION not PRESSURE
FIVE PILLOW RULE
1.      Pillow 1 under legs to elevate heels (or Prevelon Heel Protectors)
2.      Pillow 2 between ankles if on side
3.      Pillow 3 between knees if on side
4.      Pillow behind the back (unless you are using the Turn and position unit)
5.      Pillow 5 under the head
Preventive devices:
§  Heel and elbow protectors
§   Cushions (no ring shaped cushions)
§  Pillows
§  Water beds
§  Alternating pressure mattresses

DEVICES TO  PREVENTION OF FRICTION
§  Lift sheets
§  Trapeze
§  Heel and elbow pads
§  Moisturizers
§  Hydration
§  Transparent dressings
§  Skin sealants
DEVICES TO PREVENTION OF SHEAR
§  Anti-shear mattress
§  Lift sheets
§  HOB 30 degrees
§  Use pillows or wedges
§  Use Turn and Position System
2. Cleaning and dressing wound
Stage I (not broken): gently wash it with water and mild soap and pat dry
Stage II (open sore): gently wash it with saline solution each time the dressing is changed
Dressing choice includes: films, gauzes, gels, foams and treated coverings
A combination of dressing may be used
3. Wound debridement
  • Surgical debridemen                              
·         2.  Mechanical debridement                                                                    
·         3. Autolytic debridement
·         Enzymatic debridement
4.Other interventions
·         Pain management
·         Antibiotics
·         A healthy diet
·         Management of incontinence
·         Muscle spasm relief
·         Negative pressure therapy (vacuum assisted closure)

5. Surgery
  • STAGE III & IV with exudates :  flap reconstruction
COMPLICATIONS
  • Sepsis. .
  • Cellulitis. 
  • Bone and joint infections. 
  • Cancer. 
Review
  • If you see even a small change in a resident’s skin –
    TELL SOMEONE

    TELL SOMEONE, until you are SURE they hear you.
  • You have a great opportunity to positively IMPACT the health and well-being of nursing home residents.